Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry.

ABSTRACT:

Importance

In clinical trials, transcatheter aortic valve replacement (TAVR) has been shown to improve symptoms and quality of life. As this technology moves into general clinical practice, evaluation of the health status outcomes among unselected patients treated with TAVR is of critical importance.

Objective

To examine the short- and long-term health status outcomes of surviving patients after TAVR in the context of an unselected population.

Design, setting, and participants

This observational cohort study included patients with severe aortic stenosis who underwent TAVR in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy (TVT) Registry from November 1, 2011, to March 31, 2016, at more than 450 clinical sites.

Main outcom

SUBMITTER: Arnold SV 

PROVIDER: S-EPMC5408740 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature